LIG D&A: Policy-backed W500B preferred raise to accelerate missile capacity expansion
The market is pricing LIG D&A's preferred raise as dilution, but it's actually a policy-backed capacity expansion catalyst. Order backlog is set to surge from W26T in 2025 to W41T by 2028, while the stock trades at a discount to peers like Elbit Systems.
Institutional-grade analysis used by equity desks before repricing events. 8 pages.
Report fact snapshot
- Publisher
- JPMorgan
- Date
- 2026-06-26
- Type
- Company Report
- Region
- Asia Pacific, Korea
- Companies
- JPMorgan, Target, Policy, Defense
- Key signal
- 38x
The market assumes the W500B preferred raise is a sign of capital distress or dilution.
Data shows the raise is policy-backed by the National Growth Fund, proceeds are earmarked for facility CAPEX to meet accelerating missile demand, and order backlog is projected to grow 58% from W26T to W41T by 2028.
Investors should view the preferred raise as a structural capacity catalyst, not a dilutive event, and position for re-rating toward the W1.1T target.
Based on JPMorgan research, June 2026 data and regional breakdowns
Key Research Signals
Market treats preferred raise as dilutive, but it is capacity-accretive and policy-backed.
W500B raise via 876,153 preferred shares at W570,676 each; proceeds for facility CAPEX; tied to National Growth Fund; common shares unchanged at 22,000,000.
Why it matters: Identifies the exact point where consensus models diverge from actual data: the raise is a capacity catalyst, not a dilution event.
Accelerated sales recognition for UAE interceptors and Saudi/Iraq M-SAM II batteries starting 2026.
Previously guided for meaningful sales recognition from 2027; now expected from 2026; additional interceptor sales from 2026.
Why it matters: Frames the catalyst window before violent repricing begins: accelerated revenue recognition from ME contracts will trigger earnings revisions.
LIG D&A is the biggest beneficiary of the ME conflict, with accelerating demand for missiles and air-defense systems.
Expected export new order wins of W6T annually 2026-2028; order backlog growing from W26T in 2025 to W41T in 2028.
Why it matters: Tracks the capital rotation toward structural winners before it becomes consensus: LIG D&A is the primary beneficiary of a multi-year defense cycle.
What You Gain From This Report
Decision Insight
Mispricing between the market's dilution narrative and the actual capacity-accretive nature of the preferred raise is not reflected in consensus models.
Missed Risk
Missing this mispricing means underweighting a structural defense winner that is set to capture multi-year ME demand, while the stock re-rates toward W1.1T.
Timing Advantage
Acting now captures the catalyst window before accelerated revenue recognition from ME contracts triggers earnings revisions and multiple expansion.
What you miss without the full report:
- Company-level positioning and stock picks
- Valuation assumptions and model inputs
- Price target logic and catalyst timeline
Why Institutional Investors Care
Consensus models price LIG D&A's preferred raise as dilution, but the policy-backed capacity expansion is a structural catalyst for 58% backlog growth from W26T to W41T.
Capital should rotate into LIG D&A as the primary beneficiary of ME conflict-driven defense capex, away from companies without missile/air-defense exposure.
The May 2026 export data window and accelerated sales recognition for UAE/Saudi/Iraq contracts create a near-term catalyst for violent repricing.
Report Summary
The market misprices LIG D&A's preferred share issuance as dilution, but it is a policy-backed capacity catalyst tied to the National Growth Fund. Accelerating missile demand from the Middle East conflict is driving order backlog growth from W26T to W41T, a structural shift not yet priced in. This creates a re-rating opportunity for investors to position ahead of consensus.
Institutional Content Below
Full broker analysis includes detailed valuation assumptions (38x 2027E P/E), price target logic (W1.1T Dec-26), and charts showing order backlog trajectory from W26T to W41T. Access the complete JPMorgan report for institutional-grade breakdown.
Key Takeaways
- Policy-Backed Capacity Catalyst: The W500B preferred raise is backed by the National Growth Fund and earmarked for facility CAPEX, not dilution, providing a strategic catalyst for capacity expansion.
- Structural Backlog Growth: Order backlog is projected to grow 58% from W26T in 2025 to W41T by 2028, offering revenue visibility and supporting a valuation re-rating.
- ME Conflict Beneficiary: LIG D&A is the biggest beneficiary of the Middle East conflict, with expected annual export new order wins of W6T from 2026 to 2028, accelerating missile and air-defense demand.
- Accelerated Revenue Recognition: Revenue recognition for UAE interceptors and Saudi/Iraq M-SAM II batteries is now expected from 2026 instead of 2027, creating a near-term catalyst for earnings revisions.
- Valuation Discount to Narrow: The stock trades at a 42% upside to the Dec-26 PT of W1.1T, with potential for multiple expansion as customer base diversifies away from the discount to Elbit Systems.
Topics Covered
Companies Mentioned
Who this summary is for
This summary is for users researching the JPMorgan LIG D&A report. It helps users review LIG D&A: Policy-backed W500B preferred raise to accelerate missile capacity expansion coverage, key takeaways, and related broker or sector research paths across Consumer, earnings, D&A:; JPMorgan, Target.
Related Search Paths
Use these links to continue through broker, sector and report-type research summaries.
Request Full PDF Access
Get access to the full broker report, including company-level details, valuation assumptions, charts, and price target logic.
Access is provided through VIP service or request confirmation.